Cairo, Francesco http://orcid.org/0000-0003-3781-1715
Dicembrini, Ilaria
Serni, Lapo
Nieri, Michele
Bettarini, Guido
Caliri, Mariasmeralda
Pala, Laura
Mannucci, Edoardo
Barbato, Luigi
Article History
Received: 15 October 2021
Accepted: 29 November 2021
First Online: 15 January 2022
Declarations
:
: The study protocol was approved by the Ethical Board (PARODIA Project, approval number: CEAVC 30952/2019).
: Francesco Cairo has received consultancy fees and grants from Straumann and Geistlich Biomaterials. Ilaria Dicembrini has received speaking fees from Merck, Novartis, AstraZeneca, Bristol Myers Squibb, Boehringer-Ingelheim, Eli-Lilly, Novo Nordisk, Sanofi, and Novartis. Edoardo Mannucci has received consultancy fees from Merck and Novartis; speaking fees from AstraZeneca, Bristol Myers Squibb, Boehringer-Ingelheim, Eli-Lilly, Merck, Novo Nordisk, Sanofi; and Novartis, and research grants from Merck, Novartis, and Takeda. Other authors have nothing to disclose.
: Informed consent was obtained from all subjects included in the study.